November 3 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said that its standalone net profit inched up to 22.4 million levs ($13.3 million/11.5 million euro) in the first nine months of 2021 from 22.1 million levs in the same period of 2020.